53 results
8-K
ATOS
Atossa Therapeutics Inc
16 Dec 13
Entry into a Material Definitive Agreement
12:00am
samples of breast cancer and pre-cancerous lesions. The license is exclusive and world-wide outside of the European Union. Fees paid or potentially
8-K
EX-99.1
0dy89
16 Dec 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
sq3j1
10 Feb 20
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
jn8h5k
25 Sep 20
Entry into a Material Definitive Agreement
5:00pm